Home › Myelodysplastic Syndromes › New Jersey › Newark
Myelodysplastic Syndromes clinical trials in Newark, NJ
4 studies for Myelodysplastic Syndromes are looking for participants at sites in and around Newark (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RecruitingPhase 2
- Cooperman Barnabas Medical Center, Livingston · 9 mi away
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- Cooperman Barnabas Medical Center, Livingston · 9 mi away
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RecruitingPhase 1/2
- Morristown Medical Center, Morristown · 17 mi away
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
RecruitingPhase 1/2
- Atlantic Health, Morristown · 17 mi away
About Myelodysplastic Syndromes
Myelodysplastic Syndromes (MDS) are rare. They are sometimes found during a routine blood test. Learn symptoms, risk factors, and treatment options.
More about Myelodysplastic Syndromes on MedlinePlus
Myelodysplastic Syndromes trials in other cities
- Houston, TX43 studies
- Baldwin Park, CA26 studies
- New York City, NY21 studies
- Seattle, WA21 studies
- Washington, DC20 studies
- Tampa, FL19 studies
- Boston, MA19 studies
- Miami, FL17 studies
- Durham, NC14 studies
- Columbus, OH14 studies
- St. Louis, MO13 studies
- Atlanta, GA13 studies
Other studies in Newark
- Breast Cancer18 studies
- Spinal Cord Injuries13 studies
- Non-Small Cell Lung Cancer13 studies
- Acute Myeloid Leukemia12 studies
- Heart Failure10 studies
- Metastatic Cancer10 studies
- Cardiovascular Disease9 studies
- Pancreatic Cancer9 studies
- Melanoma8 studies
- Cancer (all types)7 studies
- Lung Cancer7 studies
- Crohn's Disease7 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.